Cardiac excitation-contraction coupling occurs primarily at the sites of transverse (T)-tubule/sarcoplasmic reticulum junctions. The orderly T-tubule network guarantees the instantaneous excitation and synchronous activation of nearly all Ca 2+ release sites throughout the large ventricular myocyte. Because of the critical roles played by T-tubules and the array of channels and transporters localized to the T-tubule membrane network, T-tubule architecture has recently become an area of considerable research interest in the cardiovascular field. This review will focus on the current knowledge regarding normal T-tubule structure and function in the heart, T-tubule remodelling in the transition from compensated hypertrophy to heart failure, and the impact of T-tubule remodelling on myocyte Ca 2+ handling function. In the last section, we discuss the molecular mechanisms underlying T-tubule remodelling in heart disease.
Introduction
Cardiac excitation-contraction (E-C) coupling is the central mechanism governing the heart muscle to generate sufficient contractile force and pump adequate blood to the whole body. 1 At the cellular level in ventricular myocytes, normal E-C coupling involves precise communication, i.e. local control of Ca 2+ -induced Ca 2+ release (CICR), between voltagegated L-type Ca 2+ channels (LTCCs) located mainly on the T-tubule membrane and Ca 2+ release channels/ryanodine receptor channels (RyRs) on the sarcoplasmic reticulum (SR). 2 -5 The highly organized T-tubule network forms tight physical couplings with the terminal cisternae of SR, termed dyads, at Z-line regions throughout the entire myocyte. 6 These organized fine dyadic Ca 2+ release apparatus are essential for local control of CICR, synchrony of SR Ca 2+ release, and Ca 2+ release stability during each heartbeat. The synchronized Ca 2+ release during each membrane excitation allows co-ordinated contraction among the many contractile units within each large working ventricular myocyte. Ultimately, synchronized myofilament contraction within and among millions of working ventricular myocytes will permit the heart muscle to contract and generate the maximal contractile force with the least energy cost. Thus, the organized T-tubule structure is critical for normal E-C coupling and cardiac function.
T-tubule structure
The first evidence that clearly showed the existence of transversely oriented continuous tubules in mammalian heart muscle was from light microscopy studies by Nyströ m in 1897 (see Huxley, The Croonian Lecture, 1967 7 ). In that pioneering work, India ink was injected into the heart muscle to track the extracellular space (analogous to Sulphorhodamine B that is used with fluorescence microscopy). Nyströ m detected dark lines transversely crossing the cardiac fibres at an interval equal to that of the striations. More than 60 years passed until, using electron microscopy (EM), Lindner (1957) identified T-tubules in canine ventricular myocardial cells. 8 Further studies clearly demonstrated the presence of the T-tubule system in myocardial cells of the rat, guinea pig, rabbit, cat, sheep, and human. 6,9 -12 Concomitantly, the existence of T-tubules was documented in the skeletal muscle. Among the ultrastructural studies that were conducted in skeletal muscle in the 1960s, Franzini-Armstrong and Porter 13 provided the most convincing evidence, using improved fixation methods and fish muscle fibres, clearly defining that the T-tubule system is an entity of the fine membrane continuous with the sarcolemma, distinct from the SR but uniquely associated with the SR. Her landmark findings indicated that the T-tubule system might play a prominent role in the fast intracellular conduction of the excitatory impulse, providing clear ultrastructural evidence that supported observations made by the Nobel Laureate Huxley and his colleague Taylor in 1955. 14 
In Huxley and
Taylor's seminal work on an isolated intact fibre of frog striated muscle, they used a micropipette electrode to achieve local subthreshold depolarization of the cell membrane and observed fast, transverse, two-dimensional conduction of excitation towards the central axis, which they concluded to be too fast to be mediated by simple chemical diffusion. 14 This work led to their hypothesis that a special membrane structure continuous with surface sarcolemma must be involved in relaying the signal to the SR, which we now define as E-C coupling. Since these early endeavours, we have garnered an understanding of the structure and function of T-tubules in the skeletal and cardiac muscle.
It is now well known that T-tubules are physical extensions and orderly invaginations of the surface membrane that are continuous with the extracellular space and extend deep into the interior of mammalian ventricular myocytes. 15 -19 They are perpendicular to the surface or external sarcolemma, are transverse to the longitudinal axis of myocytes, and appear to have a radial 'spoke-like' organization in transverse sections. 20, 21 They are regularly arrayed along the Z-line regions, forming a highly organized, elaborate tubular network. The majority of T-tubules are within 0.5 mm from the Z-lines. 19, 20, 22 Besides the primary transversal components of T-tubule membrane, longitudinal elements running across from one Z-line to another are also present, with some reports that longitudinal elements occur at a much lower proportion in normal healthy ventricular cells, 15, 16, 23, 24 and others that longitudinal elements are frequent in healthy myocytes. 22, 25 Quantitative measurements based on confocal microscopy approximate T-tubule diameters to be 250 nm in rat myocytes 22 and 400 nm in rabbit and human. 26, 27 A recent study using stimulated emission depletion (STED) imaging technique indicated that the T-tubule diameter is 200 nm in murine myocytes. 25 (Note: the smaller T-tubule diameter detected by STED imaging could be due to a better spatial resolution offered by this technique than confocal microscopy). The lumens of T-tubules have notable variations in size (even within the same species). 22, 26 Although the volume density of the T-tubule system is only 1-3%, 22, 28 it represents about one-third of the entire cell-membrane area 1, 29, 30 ( Figure 1) .
It is believed that T-tubule density varies among ventricular myocytes from different species. Early EM work and recent confocal imaging studies suggested that rodents (mouse, rat), which have faster heart rates, have a higher T-tubule density in ventricular myocytes relative to larger mammalian myocytes (i.e. rabbit, pig, and human), but the difference is not related to cell or heart size. 31, 32 In contrast, mammalian atrial myocytes have a heterogeneous distribution of the tubular system, with the longitudinal components more prominent, 33 -36 (see review by
Katherine Dibb and colleagues in this issue). In Purkinje fibres of the conduction system, early EM studies found a lack of T-tubules. 37 -40 However, work by Franzini-Armstrong and colleagues as well as others demonstrated that T-tubules are occasionally present in all Purkinje fibres and form dyadic associations with the SR, with the frequency of T-tubules varying depending on the size of the animal.
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Figure 1 T-tubule remodelling and heart failure pathogenesis
As an additional note, the cardiac myocytes of reptiles, birds, and fish are devoid of a T-tubule system in both atria and ventricles. 16 The following discussion will focus on mammalian ventricular myocytes.
T-tubule function: synchronous Ca 21 release
Critical to E -C coupling function is the spatial relationship between T-tubules and the SR where Ca 2+ release channels or RyRs are located ( Figure 2) . In normal ventricular myocytes, about 80% of LTCCs localize to the T-tubules. 43 T-tubules and the junctional components of SR (jSRs) juxtapose and form the dyadic junctions. Both ultrastructural and functional studies have suggested that dyadic junctions are much more abundant in the T-tubules than at the surface membrane, e.g. in rat 75% of dyads are in T-tubule region compared with 25% at the surface sarcolemma, 31, 44 indicating the importance of the T-tubule membrane in controlling CICR and E-C coupling function. Figure 3A and B). 47 In combination with loose seal patch clamp and confocal 
T-tubule remodelling in heart failure
T-tubule alterations were first observed in diseased hearts by EM. Earlier work by Page and McCallister 49 showed that, in a rat pressure overload hypertrophy model (10 days after aortic constriction), the area of T-tubule membrane is increased in hypertrophied myocytes and accordingly the ratio of total sarcolemmal area to cell volume remains constant. These findings were extended by subsequent EM studies from Maron et al., 50 which included analysis of biopsies from human hypertrophied cardiomyopathies of various causes, including aortic stenosis, aortic regurgitation, obstructive LV outflow, etc. They identified irregularly shaped or dilated T-tubules in hypertrophied cells and loss of T-tubules in degenerating cells. 50 Similar T-tubule alternations (dilation and loss of T-tubules) were also revealed in patient hearts with end-stage dilated or ischaemic cardiomyopathy. 20, 51, 52 Although these early EM studies provided highresolution visualization of myocyte ultrastructure, application of EM is limited both by the sophisticated technique, including sample processing, and by the inability to view in a single image the complete T-tubule system of a myocyte. The appreciation of T-tubule remodelling in heart disease was boosted during the last decade by the application of laser scanning confocal microscopy and the use of fluorescent lipophilic membrane markers. Among these, He et al. 53 were the first to identify and quantify the significant loss of T-tubule density in failing ventricular myocytes in an experimental pacing-induced canine heart failure model, though the overall organized pattern of the T-tubule network is not altered in this model. Similar findings using the same model were reported from this group. 54 Interestingly, in a spontaneously hypertensive rat model, distinct changes in the T-tubule system in failing myocytes were found, specifically, a dramatic re-organization of the T-tubule system characterized by a loss of transverse elements but a gain in longitudinal elements, giving rise to an overall chaotic appearance of the T-tubule network ( Figure 4 ). 23 These visual observations from confocal images were confirmed by computational analysis including 2D Fourier analysis of the power of the T-tubule structure, which represents the global regularity of the T-tubule network, and calculation of the densities of transversal and longitudinal elements of the T-tubules. 23 Subsequently, many other groups using other animal heart failure models have also reported profound T-tubule remodelling in single isolated failing myocytes (Table 1) . 21,24,25,32,55 -67 Similar alterations were also observed in atrial myocytes following rapid pacing. 35, 58 Taken together, these studies provide clear evidence that T-tubule remodelling is a common pathological alteration in failing myocytes of almost all origins examined to date, including different animal heart failure models of different species/aetiologies, and human heart failure patients with different background diseases.
The major common characteristics of T-tubule alterations from these studies include the following: (i) loss of T-tubules (or reduction in T-tubule density); (ii) disorganization or disruption of the orderly arrayed T-tubule network; (iii) a decrease in transversal elements and an increase in longitudinal elements; and (iv) an increase in T-tubule diameter (or T-tubule dilation). These studies led to the current paradigm that T-tubule remodelling is a principal problem in many forms of cardiac disease that share the common end-stage of heart failure. It should be noted that one study found minor and insignificant changes in T-tubule structure in single myocytes isolated from end-stage human failing hearts compared with control samples from rejected healthy donor hearts. 68 
T-tubule remodelling in the transition from hypertrophy to heart failure
Although a majority of studies agree that there is remarkable remodelling within the T-tubule system in myocytes isolated from failing hearts, it is arguable that the disruptive T-tubule remodelling might be a consequence of complex molecular and biochemical changes during heart failure. It is therefore imperative to investigate the evolution of T-tubule remodelling during the development of heart failure, in other words, how early T-tubule remodelling initiates in the process of progression from hypertrophy to heart failure. Previous studies from other groups have been performed in isolated single myocytes, though enzymatic dissociation of myocytes may impair the T-tubule membrane of healthy cells. 69 Myocytes at the ).
T-tubule remodelling and heart failure pathogenesis . hypertrophied stage may undergo subtle changes in the T-tubule network, which could be indistinguishable from controls in isolated myocytes. Therefore, it was necessary to develop a new imaging technique to detect T-tubule structure with higher sensitivity and less damage. With this in mind, we developed an in situ T-tubule confocal imaging technique by combining the Langendorff perfusion system with laser scanning confocal microscopy ( Figures 5 and 6) . In doing so, a fluorescent dye-loaded intact heart can be imaged in situ for T-tubule ultrastructure or other structures that can be visualized using fluorescent dyes in living cells, with minimal damage to the myocytes. In a pressure overload hypertrophy -heart failure rat model, this novel advanced in situ confocal imaging provided convincing evidence that T-tubule remodelling is a real phenomenon in failing hearts, 60 rather than the previously postulated experimental artefact related to the isolation of failing cardiomyocytes. 69 Moreover, this in situ imaging approach revealed that T-tubule remodelling is not just a manifestation of end-stage heart failure. 60 Instead, the remodelling of T-tubules starts much earlier in the disease spectrum, even prior to echocardiographically detectable LV systolic dysfunction. The T-tubule system in the LV undergoes progressive deterioration from compensated hypertrophy through early heart failure to advanced heart failure. 60 With progression from compensated hypertrophy to early and late heart failure, T-tubule remodelling spreads from the LV to the RV. These findings that T-tubule remodelling occurs prior to the onset of heart failure suggest that T-tubule remodelling is not a secondary modification after heart failure, but instead is an important early event during heart-failure progression. Data from this study also showed that T-tubule integrity highly correlates with cardiac ejection fraction of diseased hearts, indicating T-tubule integrity is a crucial determinant of cardiac function. 60 Taken together, these studies strongly suggest that maladaptive T-tubule remodelling is a causal event that drives the transition from compensated hypertrophy to heart failure.
T-tubule remodelling leads to defective E -C coupling in heart failure
To date, accumulating evidence supports that alterations in T-tubule structure are an important factor in Ca 2+ handling dysfunction in car- Impaired E -C coupling, characterized by a reduction in the amplitude of Ca 2+ release and slowed kinetics, including both time to peak and decay rate of Ca 2+ transients, is a hallmark of heart failure. 74 -77 Decreased SR Ca 2+ content due to SERCA down-regulation, 78 -85 reduction in Ca 2+ influx through LTCCs, 86,87 NCX upregulation, 88 -94 and metabolic inhibition 95 -98 are among the mechanisms responsible for altered E-C coupling and Ca 2+ homeostasis during heart failure.
The contribution of structural alterations to cardiac E -C coupling dysfunction was not appreciated until the seminal work led by Lederer et al. 99 In that study, it was first proposed that defective E-C coupling is likely due to a change in the relationship between RyRs on the SR and LTCCs on T-tubules, although no direct evidence was provided. 99 Later, dyssynchronous Ca 2+ sparks were documented in failing myocytes following myocardial infarction; however, the mechanism causing dyssynchrony of SR Ca 2+ release was not completely understood. 87 As summarized in Table 1 , in the last 10 years, evidence from isolated ventricular myocytes and intact hearts suggests that T-tubule loss and/or disorganization is a significant and common event in advanced heart failure of different aetiologies and results in dyssynchronous Ca 2+ release and impaired contraction. The re-organization of T-tubule structure alters the spatial organization between LTCCs and RyRs, leading to a reduction in co-localization between RyRs and LTCCs, an increase in orphaned RyRs, the loss of local control of RyRs by LTCCs, and therefore decreased E-C coupling efficacy and increased dyssynchrony of SR Ca 2+ release in failing myocytes. 23 Specifically, evidence from the study using spontaneously hypertensive rats revealed that, when uncoupled RyRs due to T-tubule disruption are not activated by LTCCs upon membrane depolarization, those uncoupled RyRs can be activated later by Ca 2+ diffused from neighbouring functionally normal release sites, causing propagative or secondary CICR. The secondary CICR is much slower compared with the primary Ca efficiency of the coupling of Ca 2+ influx to Ca 2+ release. 32 T-tubule remodelling and Ca 2+ release dysfunction have also been observed in atrial myocytes from a rapid-pacing-induced sheep heart-failure model. 58 These experimental findings are supported by computational modelling in which T-tubule re-organization reduces the synchrony of Ca 2+ spark production, leading to the appearance of late Ca 2+ sparks and a greater non-uniformity of intracellular Ca 2+ . 27 In addition to its influence on the activation process of Ca 2+ release, T-tubule remodelling also affects Na + /Ca 2+ exchanger (NCX)-mediated Ca 2+ removal process, slowing the kinetics of Ca 2+ decay during diastole and thus impairing myocardial relaxation. This occurs because NCX is preferentially located to T-tubules ( Figure 2 ) and is the major sarcolemmal Ca 2+ efflux mechanism in cardiomyocytes ( Figure 2 ). 32, 73, 100, 101 T-tubule integrity is crucial for instantaneous action potential propagation across the whole membrane system of the large myocyte. Recent investigations in rat failing myocytes post-myocardial infarction indicate that structural disorganization of the T-tubule system worsens the electrical coupling between the T-tubule system and the surface sarcolemma, leading to the failure of action potential propagation from the surface membrane to T-tubule system and ensuing triggering of SR Ca 2+ release. 102 It is then suggested that, in addition to orphaned RyRs, Ca 2+ release units that are coupled to the dysfunctional T-tubule domain may also fail to be recruited to release Ca 2+ . Interestingly, in a mouse hypertrophy model of Gaq overexpression, Rubart and colleagues 103 found that T-tubule remodelling is associated with spatially non-uniform action potential prolongation and alterations in spatial dispersion of epicardial repolarization, but found no changes in electrical coupling. Nevertheless, these studies provide new insights into our understanding of the contribution of T-tubule remodelling to defective E-C coupling in heart failure. The T-tubule system harbours many important ion channels or transporters. In addition to those depicted in Figure 2 , brain-type sodium channels and potassium channels (especially the steady-state component, IKss) are also concentrated at T-tubules. 104 T-tubule remodelling could change the distribution or organization of ion channels and transporters, alter ion exchange between the restricted T-tubule lumen and the bulk extracellular space, and therefore alter the shape and duration of action potentials, which in turn would disturb the synchrony and efficacy of SR Ca 2+ release and Ca 2+ removal. 104 -107 In addition, T-tubule remodelling causes redistribution and loss of b-adrenergic receptors in T-tubules in cardiomyocytes. The impact of this profound change on myocyte E-C coupling is extensively discussed in the review by Gorelik and colleagues in this issue. 108 Briefly, myocyte T-tubule remodelling leads to alterations at multiple levels, including (ultra)structural, electrical, and signal transduction, collectively contributing to the progression of cardiac failure and the genesis of fatal arrhythmias ( Figure 7 ).
Molecular mechanisms of T-tubule remodelling
Junctophilin-2 (JP2) bridges the physical gap between the plasma membrane and the SR in excitable cells and plays an important role in the formation of the junctional membrane complex (i.e. the cardiac dyad-T-tubule/SR couplings). 109 JP2 is one of the four members of the junctophilin protein family (JP1 -4), and the only junctophilin protein expressed in cardiac muscle. 109 -111 Conventional knockout of JP2 is embryonically lethal, and studies in embryonic myocytes with JP2 deficiency define a critical requirement for JP2 in normal cardiac function. Specifically, JP2-deficient embryonic myocytes have defective cardiac dyads, including more SR segments with no T-tubule couplings as well as reduced and unstable intracellular Ca 2+ transients. 109 These pioneering studies identified JP2 as a critical structural factor for normal E-C coupling and cardiac function. Very recent work by Sachse and colleagues 112, 113 suggests that cellular strain (including passive stretch and active myocyte contraction) could affect the geometry of T-tubules. Thus, maintaining a stable physical relationship between T-tubules and the jSR is critical for normal E -C coupling function during active myocyte Figure 7 Schematic chart depicting the consequences of T-tubule remodelling and the relationship with heart failure and Ca 2+ -dependent arrhythmogenesis. Myocyte T-tubule remodelling leads to alterations at multiple levels, including ultrastructural, electrical, and signal transduction changes, collectively contributing to the progression of cardiac failure and the genesis of fatal arrhythmias.
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contraction-relaxation cycle. From this point of view, we consider JP2 as an anchoring protein that helps maintain both the static and dynamic stability of the nano-positioning between T-tubule and jSR. Given the clear role of JP2 in normal cardiac function, recent work has evaluated how expression of JP2 changes in response to cardiac stress, and if changes in JP2 mechanistically contribute to pathological T-tubule remodelling. Loss of JP2 expression has been documented in failing human hearts and a variety of heart failure models. For example, in rat pressure overload models, 60, 77, 114 murine myocardial infarction model, 115 murine hypertrophic or dilated cardiomyopathy models, 116 and human failing hearts, 117 expression of JP2 is severely downregulated in response to cardiac stress. This loss of JP2 expression correlates with loss of T-tubule structural integrity. 60 Recent studies in which JP2 was knocked down in either cultured ventricular myocytes or by transgenic expression of a JP2 shRNA in vivo suggest that loss of JP2 expression is a key mechanism underlying T-tubule remodelling in failing myocytes. Since JP2 structurally connects the T-tubules and SR and maintains the physical stability of T-tubule/SR junctions, JP2 down-regulation likely leads to T-tubule dissociation from the SR and ensuing disruption of cardiac dyads. Indeed, the effects of knockdown of JP2 mimic the loss of T-tubule/SR organization observed in response to cardiac stress. 60, 118 Towards understanding the mechanism by which JP2 is down-regulated in failing hearts, microRNA-24 (miR-24) has been identified as direct regulator of JP2 homeostasis in the heart. 119 miRNAs are now recognized as important regulators of both normal and pathophysiological processes. Expression of miR-24 is increased in failing hearts, and overexpression of miR-24 in cultured myocytes results in JP2 down-regulation, alterations in cardiac dyads, and changes in E-C coupling function. 119 Taken together, compelling evidence specifically identifies JP2 as a key mediator of stress-induced cardiac T-tubule remodelling. In addition to JP2, other proteins have been implicated in T-tubule formation or remodelling, such as caveolin-3, amphyphisin-2 (Bin1), telethonin (Tcap), particularly in skeletal muscle. 18,120 -124 However, the roles of these proteins in T-tubule biogenesis and pathogenesis in cardiomyocytes remain to be determined. Newly published work (2013) from the Terracciano group using Tcap knockout mice began to shed new light into these curiosities, indicating that Tcap is a critical, load-sensitive regulator of T-tubule structure and function. 125 
Conclusions
In summary, data from electron microscopy and confocal imaging of isolated myocytes and, more recently, in situ confocal imaging of myocytes in intact hearts have provided a clear understanding of the structure of T-tubules. We now recognize T-tubules as an important structural component of E -C coupling function that, when perturbed, results in loss of co-ordinated contraction of ventricular myocytes, and T-tubule remodelling is a key player in the pathogenesis of heart failure. While the composition of the T-tubule network is fairly well-understood, we are beginning to discover the mechanistic underpinnings of T-tubule remodelling, with JP2 emerging as a clear factor regulating T-tubule integrity. Future studies are warranted to answer the following questions: (i) What is the role and pathological significance of longitudinal elements in the process of heart disease?
(ii) What is the role of JP2 in T-tubule development? (iii) How does JP2 become dysregulated at both the transcriptional and posttranslational levels in response to cardiac stress? (iv) JP2 is very likely not the sole molecule responsible for T-tubule integrity in health and disease. What other players are critically involved? And how? Is there any interplay between JP2 and others factors in development, healthy adults, and disease? By achieving a complete mechanistic understanding of how T-tubule integrity is developed and maintained in health and how it is lost with disease progression, we are one step closer to identifying novel strategies that improve cardiac function and decrease mortality and morbidity associated with heart failure.
